Didier Raoult co-signed the study pre-published last April on a clinical trial conducted on more than 30,000 patients during the Covid pandemic. It has not been peer reviewed or published in a scientific journal.
The National Agency for the Safety of Medicines and Health Products (ANSM) indicates this Saturday to BFMTV that it will take legal action in relation to a study co-signed by Didier Raoult regarding treatment with hydroxychloroquine and carried out on more than 30,000 patients between 2020 and 2021, confirming information from Parisian.
“(The study) should have received a favorable opinion from a committee for the protection of people and authorization from the ANSM to be implemented. The ANSM is thus preparing to take legal action again “, confirms on the” preprint “published in May by Didier Raoult and his team.
>> More information to come at BFMTV.com
Source: BFM TV
